![](media/image1.png){width="5.972916666666666in"
height="0.4791666666666667in"}

Top of Form

## Complete Summary

#### TITLE

Haemodialysis-associated blood stream infection: percentage of
AV-fistula access-associated blood stream infections, during the 6 month
time period.

#### SOURCE(S)

Australian Council on Healthcare Standards (ACHS). ACHS clinical
indicator users\' manual 2008. ULTIMO NSW: Australian Council on
Healthcare Standards (ACHS); 2007 Dec. 776 p.

### Measure Domain

#### PRIMARY MEASURE DOMAIN

Outcome

The validity of measures depends on how they are built. By examining the
key building blocks of a measure, you can assess its validity for your
purpose. For more information, visit the [Measure
Validity](http://www.qualitymeasures.ahrq.gov/resources/measure_domains.aspx)
page.

#### SECONDARY MEASURE DOMAIN

Does not apply to this measure

### Brief Abstract

#### DESCRIPTION

This measure is used to assess the percentage of arteriovenous
(AV)-fistula access-associated blood stream infections, during the 6
month time period.

The rate of haemodialysis-associated blood stream infection (BSI) for
this indicator is expressed per 100 patient months.

#### RATIONALE

Dialysis-associated blood stream infections cause considerable
morbidity. A proportion of infections are potentially preventable
through adherence to appropriate standards of care and the avoidance
where possible of devices that have more frequent occurrence of
infection.

#### PRIMARY CLINICAL COMPONENT

Haemodialysis-associated blood stream infection; arteriovenous
(AV)-fistula access

#### DENOMINATOR DESCRIPTION

Total number of patient-months for patients dialysed through
arteriovenous (AV)-fistula, during the 6 month time period (see the
related \"Denominator Inclusions/Exclusions\" field in the Complete
Summary)

#### NUMERATOR DESCRIPTION

Total number of arteriovenous (AV)-fistula access-associated blood
stream infections, during the 6 month time period (see the related
\"Numerator Inclusions/Exclusions\" field in the Complete Summary)

### Evidence Supporting the Measure

#### EVIDENCE SUPPORTING THE CRITERION OF QUALITY

-   A formal consensus procedure involving experts in relevant clinical,
    methodological, and organizational sciences

### Evidence Supporting Need for the Measure

#### NEED FOR THE MEASURE

Use of this measure to improve performance

#### EVIDENCE SUPPORTING NEED FOR THE MEASURE

Australian Council on Healthcare Standards (ACHS). Australian clinical
indicator report 1998-2006. Determining the potential to improve quality
of care: 8th edition. ULTIMO NSW: Australian Council on Healthcare
Standards (ACHS); 2007. 564 p.

### State of Use of the Measure

#### STATE OF USE

Current routine use

#### CURRENT USE

Internal quality improvement

### Application of Measure in its Current Use

#### CARE SETTING

Ambulatory Care\
Hospitals

#### PROFESSIONALS RESPONSIBLE FOR HEALTH CARE

Physicians

#### LOWEST LEVEL OF HEALTH CARE DELIVERY ADDRESSED

Single Health Care Delivery Organizations

#### TARGET POPULATION AGE

Unspecified

#### TARGET POPULATION GENDER

Either male or female

#### STRATIFICATION BY VULNERABLE POPULATIONS

Unspecified

### Characteristics of the Primary Clinical Component

#### INCIDENCE/PREVALENCE

Unspecified

#### ASSOCIATION WITH VULNERABLE POPULATIONS

Unspecified

#### BURDEN OF ILLNESS

Unspecified

#### UTILIZATION

Unspecified

#### COSTS

Unspecified

### Institute of Medicine National Healthcare Quality Report Categories

#### IOM CARE NEED

Living with Illness

#### IOM DOMAIN

Effectiveness\
Safety

### Data Collection for the Measure

#### CASE FINDING

Users of care only

#### DESCRIPTION OF CASE FINDING

Patient-months for patients dialysed through arteriovenous (AV)-fistula,
during the 6 month time period

#### DENOMINATOR SAMPLING FRAME

Patients associated with provider

#### DENOMINATOR INCLUSIONS/EXCLUSIONS

**Inclusions**\
Total number of patient-months for patients dialysed through
arteriovenous (AV)-fistula, during the 6 month time period

Refer to the original measure documentation for International
Classification of Diseases, Tenth Revision, Australian Modification
(ICD-10-AM) procedure codes for haemodialysis.

**Exclusions**\
Unspecified

#### RELATIONSHIP OF DENOMINATOR TO NUMERATOR

All cases in the denominator are equally eligible to appear in the
numerator

#### DENOMINATOR (INDEX) EVENT 

Encounter\
Therapeutic Intervention

#### DENOMINATOR TIME WINDOW

Time window brackets index event

#### NUMERATOR INCLUSIONS/EXCLUSIONS

**Inclusions**\
Total number of arteriovenous (AV)-fistula access-associated blood
stream infections, during the 6 month time period

**Notes**:

-   Diagnosis of blood stream infection (BSI) must meet specific
    criteria set out in Appendix 6 of the original measure
    documentation.

-   Haemodialysis-associated BSI is defined as a BSI without an apparent
    focus of infection or where there is clinical infection at the site
    of the vascular access.

Refer to the original measure documentation for International
Classification of Diseases, Tenth Revision, Australian Modification
(ICD-10-AM) codes for BSI.

**Exclusions**\
Unspecified

#### MEASURE RESULTS UNDER CONTROL OF HEALTH CARE PROFESSIONALS, ORGANIZATIONS AND/OR POLICYMAKERS

The measure results are somewhat or substantially under the control of
the health care professionals, organizations and/or policymakers to whom
the measure applies.

#### NUMERATOR TIME WINDOW

Fixed time period

#### DATA SOURCE

Administrative data\
Medical record

#### LEVEL OF DETERMINATION OF QUALITY

Not Individual Case

#### OUTCOME TYPE

Adverse Outcome

#### PRE-EXISTING INSTRUMENT USED

Unspecified

### Computation of the Measure

#### SCORING

Rate

#### INTERPRETATION OF SCORE

Better quality is associated with a lower score

#### ALLOWANCE FOR PATIENT FACTORS

Unspecified

#### STANDARD OF COMPARISON

External comparison at a point in time\
External comparison of time trends\
Internal time comparison

### Evaluation of Measure Properties

#### EXTENT OF MEASURE TESTING

Unspecified

### Identifying Information

#### ORIGINAL TITLE

Indicator area 3: infection surveillance CI 3.1.

#### MEASURE COLLECTION

[Australian Council on Healthcare Standards (ACHS) Equip Clinical
Indicators](http://www.qualitymeasures.ahrq.gov/Browse/DisplayOrganization.aspx?org_id=1984&doc=11061)

#### MEASURE SET NAME

[Infection Control
Indicators](http://www.qualitymeasures.ahrq.gov/Browse/DisplayOrganization.aspx?org_id=1984&doc=11835)

#### DEVELOPER

Australian Council on Healthcare Standards

#### FUNDING SOURCE(S)

Funding is direct Australian Council on Healthcare Standards (ACHS)
funding sourced through our membership. ACHS does not receive external
funding from the government or other sources.

#### COMPOSITION OF THE GROUP THAT DEVELOPED THE MEASURE

Our terms of reference dictate the composition of the working parties
that develop our indicators and include the following:

-   Two Clinicians \-- nominated by the relevant specialty
    college/association/society, one nominated to be the chair of the
    working party

-   Private Hospital Representative \-- nominated by the Australian
    Private Hospital Association

-   Consumer Representative \-- nominated by the Consumer Health Forum
    of Australia

-   Coding Representative \-- nominated by the National Centre for
    Clinical classification on Health

-   Quality Health New Zealand, nominated by QHNZ (if applicable)

-   Epidemiological/Clinical Research Representative, Director of Health
    Services Research Group, University of Newcastle

-   Australian Council on Healthcare Standards (ACHS) Representatives
    \-- Clinical Director, Coordinator, Administrative Assistant

-   Other Expert Stakeholders, as required

#### FINANCIAL DISCLOSURES/OTHER POTENTIAL CONFLICTS OF INTEREST

None

#### ADAPTATION

These indicators have been replicated with permission, from the New
South Wales (NSW) Health Department Infection Control Program Quality
Monitoring Indicators Version 2.

The Australian Council on Healthcare Standards (ACHS) Infection Control
Indicators were developed in accordance with the standard set of
definitions published by the Australian Council for Safety and Quality
in Health Care\'s, Health Care Associated Infections Advisory Committee
(HCAIAC) and Surveillance Working Party. The definitions were originally
developed by the National Advisory Board of the Australian Infection
Control Association based on the National Nosocomial Infections
Surveillance Systems, the Nosocomial Infection National Surveillance
System and from the Public Health Laboratory Service of the UK (PHLS).

#### RELEASE DATE

2002 Jan

#### REVISION DATE

2007 Dec

#### MEASURE STATUS

This is the current release of the measure.

#### SOURCE(S)

Australian Council on Healthcare Standards (ACHS). ACHS clinical
indicator users\' manual 2008. ULTIMO NSW: Australian Council on
Healthcare Standards (ACHS); 2007 Dec. 776 p.

#### MEASURE AVAILABILITY

The individual measure, \"Indicator Area 3: Infection Surveillance CI
3.1,\" is published in \"ACHS Clinical Indicator Users\' Manual 2008.\"

For more information contact, the Australian Council on Healthcare
Standards (ACHS), 5 Macarthur Street, ULTIMO NSW 2007; Phone: (02) 9281
9955; Fax: (02) 9211 9633; E-mail: <pos@achs.org.au>; Web site:
[www.achs.org.au](http://www.achs.org.au/).

#### COMPANION DOCUMENTS

The following is available:

-   Australian Council on Healthcare Standards (ACHS). Australian
    clinical indicator report 1998-2006. Determining the potential to
    improve quality of care: 8th edition. ULTIMO NSW: Australian Council
    on Healthcare Standards (ACHS); 2007. 564 p. This document is
    available in Portable Document Format (PDF) from the [Australian
    Council on Healthcare Standards (ACHS) Web
    site](http://www.achs.org.au/pdf/Australasian_CIR_8th_Edition.pdf).

#### NQMC STATUS

This NQMC summary was completed by ECRI Institute on August 13, 2008.

#### COPYRIGHT STATEMENT

This NQMC summary is based on the original measure, which is subject to
the measure developer\'s copyright restrictions. This work is copyright.
Apart from any use as permitted under the Copyright Act 1968, no part
may be reproduced by any process without written permission from The
Australian Council on Healthcare Standards (ACHS).

### Disclaimer

#### NQMC DISCLAIMER

The National Quality Measures Clearinghouse™ (NQMC) does not develop,
produce, approve, or endorse the measures represented on this site.

All measures summarized by NQMC and hosted on our site are produced
under the auspices of medical specialty societies, relevant professional
associations, public and private organizations, other government
agencies, health care organizations or plans, individuals, and similar
entities.

Measures represented on the NQMC Web site are submitted by measure
developers, and are screened solely to determine that they meet the NQMC
Inclusion Criteria which may be found at
<http://www.qualitymeasures.ahrq.gov/about/inclusion.aspx>.

NQMC, AHRQ, and its contractor ECRI Institute make no warranties
concerning the content or its reliability and/or validity of the quality
measures and related materials represented on this site. The inclusion
or hosting of measures in NQMC may not be used for advertising or
commercial endorsement purposes.

Readers with questions regarding measure content are directed to contact
the measure developer.

Bottom of Form

© 2008 National Quality Measures Clearinghouse

Date Modified: 12/15/2008